KZIA Kazia Therapeutics Limited
$11.19▲ +1.63%
Healthcare
Other
After hours
$11.19▲ +0.00%
Sep 11, 7:30 PM ET
Volume 340.7K
Avg Volume (10D) 511.3K
Key Metrics & Fundamentals
Market Cap
$127.87M
P/E Ratio
–
Div Yield
–%
52W Range
4.86 - 17.40
% vs 50 MA
-14.76%
% vs 200 MA
5.41%
RSI-14
38.9
MACD Histogram
-0.3200
Beta (1Y vs SPY)
2.16
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
PR Newswire · Sep 9, 2026 11:30 AM
Kazia (KZIA) Raises Approximately $40M in Gross Proceeds and Expands Paxalisib. Is the Capital Base Stronger than the Clinical Evidence?
Insider Monkey · Sep 9, 2026 4:05 AM
Kazia Therapeutics Reports Preclinical Tumor Reduction in Colorectal Cancer Study
MT Newswires · Sep 1, 2026 12:30 PM
Kazia Therapeutics Expands Paxalisib Trial Into HR+/HER2- Breast Cancer
MT Newswires · Sep 1, 2026 11:57 AM
Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy
CNW Group · Sep 1, 2026 11:30 AM
Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer
CNW Group · Sep 1, 2026 11:15 AM
Kazia closes oversubscribed offering to fund paxalisib’s clinical development
Pharmaceutical Technology · Sep 1, 2026 9:52 AM
Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering
PR Newswire · Aug 31, 2026 11:23 PM
Kazia Therapeutics Prices $40 Million Public Offering
MT Newswires · Aug 28, 2026 12:00 PM
Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
PR Newswire · Aug 28, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for KZIA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.